ReproUnion
Reproductive Medicine Across BordersInfertility is a common chronic disease in the age group 20-45 years, affecting one in four Nordic couples. In the future, even more are expected to suffer from infertility due to factors such as age, lifestyle, and environmental exposures. Projections show that due to an increased demand for fertility treatments the industry is expected to grow by approx. 16% globally between 2020-2027.
During 15 years, ReproUnion has been driving collaboration across borders and disciplines between academia, hospitals, and industry. Our aim is to understand the underlying reasons of infertility and to personalise and improve reproductive treatment. To do so, ReproUnion is building an innovation platform to help the industry gain access to cutting-edge expertise and research infrastructure. Our new entrepreneurial setting is also inspiring the utilization of public research in patents and future spin-outs.
News
Find out what’s going on & stay up to date
New study links semen quality to men’s lifespan – a landmark study featured in media across the world!
Human Reproduction has published the findings from the largest existing study, to examine the link between semen quality and mortality, based on data from nearly 80,000 men. The main authors are also part of ReproUnion.
Dx4Life completes clinical trial – a step towards CE marking of a diagnostic tool for guidance in hormonal choice prior to fertility treatment
Dx4Life is the first start-up to emerge from the ReproUnion Innovation Platform, and the collaboration with RMC is a strong example of the translational research that ReproUnion fosters to bridge the gap between laboratory discoveries and clinical application.
Innovation workshop sparks entrepreneurial thinking amongst clinicians
At the workshop, co-organized with LU Innovation and Reproduktionmedicinskt Centrum (RMC), the clinicians explored an innovation framework which underlines the distinction that an invention isn’t truly an innovation until it’s successfully implemented.
